SynthesisBMC oral health2025
AXIN2 variants, tooth agenesis, and cancer risk: a systematic review.
Synthesis in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Signaling-Threshold Framework for Human Tooth Agenesis: Integrating Molecular Genetics with Developmental Field Theory.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundVariants in the Axis Inhibition Protein 2 (AXIN2) have been associated with tooth agenesis, a congenital condition characterized by missing teeth, and an increased risk of various cancers. Studies suggest that individuals with AXIN2 variants may exhibit both dental anomalies and a predisposition to malignancies, particularly colorectal cancer. This raises the possibility that tooth agenesis could serve as an early clinical marker for identifying individuals at higher cancer risk.
methodA systematic review was conducted using data from 20 studies with 91 patients carrying 34 unique AXIN2 variants. The number and pattern of missing teeth, as well as the occurrence of cancer types, were evaluated. The genotypic location of AXIN2 variants was also assessed for clinical significance.
resultsMost AXIN2 variants were located within the SMAD3 domain. Patients with both tooth agenesis and cancer were more common than those with either condition alone. Among the mutation types, nonsense AXIN2 variants were associated with the most severe tooth agenesis phenotype, averaging 12.9 missing teeth. Second premolars were most frequently missing, and maxillary central incisors were least affected. Regarding cancer, colorectal cancer and polyps were the most common malignancies observed in both sexes, followed by breast and ovarian cancer in females and skin cancer in males.
conclusionsTooth agenesis, especially in individuals with AXIN2 variants affecting the SMAD3 domain, may serve as a clinical marker for identifying individuals at increased cancer risk. Recognizing congenital missing teeth in patients with AXIN2 mutations can aid in early cancer screening, improving early detection and outcomes through timely interventions and surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.